menu
    • menu

    Company profile for Q32 Bio

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Q32 Bio has advanced a strong clinical and discovery pipeline based on the body’s innate and adaptive immune systems and the drive to restore immune homeostasis in patients with severe inflammatory and autoimmune diseases. With an expert team comprised of highly skilled drug developers and immunology experts from the biotech/biopharma industry, Q32 Bio is well-positioned to deliver on its mission to bring new therapeutics to...
    Q32 Bio has advanced a strong clinical and discovery pipeline based on the body’s innate and adaptive immune systems and the drive to restore immune homeostasis in patients with severe inflammatory and autoimmune diseases. With an expert team comprised of highly skilled drug developers and immunology experts from the biotech/biopharma industry, Q32 Bio is well-positioned to deliver on its mission to bring new therapeutics to patients with severe inflammatory and autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Q32 BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Broadway, 11th Floor, Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.q32bio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/q32-bio-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Q32Bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Q32 Bio To Join Oppenheimer Healthcare Life Sciences Conference
    Q32 Bio To Join Oppenheimer Healthcare Life Sciences Conference

    18 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q32-bio-to-participate-in-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-302689781.html

    PR NEWSWIRE
    18 Feb 2026
    Share Share
    Akebia Announces Establishment Of Rare Kidney Disease Pipeline
    Akebia Announces Establishment Of Rare Kidney Disease Pipeline

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196841/37519/en/Akebia-Announces-Establishment-of-Rare-Kidney-Disease-Pipeline.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Q32 Bio Announces Q3 2025 Financial Results And Corporate Update
    Q32 Bio Announces Q3 2025 Financial Results And Corporate Update

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q32-bio-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302613664.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Q32 Bio Completes Enrollment In SIGNAL-AA Phase 2A Trial
    Q32 Bio Completes Enrollment In SIGNAL-AA Phase 2A Trial

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q32-bio-announces-completion-of-enrollment-in-part-b-of-signal-aa-phase-2a-clinical-trial-of-bempikibart-for-alopecia-areata-302589401.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    Q32 Bio to Attend 2025 Wells Fargo Healthcare Conference
    Q32 Bio to Attend 2025 Wells Fargo Healthcare Conference

    28 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q32-bio-to-participate-in-the-2025-wells-fargo-healthcare-conference-302540421.html

    PR NEWSWIRE
    28 Aug 2025
    Share Share
    Q32 Bio Reports Q2 2025 Financials and Updates on Corporate
    Q32 Bio Reports Q2 2025 Financials and Updates on Corporate

    07 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q32-bio-reports-second-quarter-2025-financial-results-and-provides-corporate-update-302523044.html

    PR NEWSWIRE
    07 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search